Molecular and cellular signatures accompanying early disease clearance in Ulcerative Colitis patients treated with vedolizumab in the VERDICT trial. - Powell, N.; Mehandru, S.; Silverberg, M.; Peyrin-Biroulet, L.; Hernandez-Rocha, C.; Colombel, J. F.; D’Haens, G.; Moran, G.; Sebastian, S.; Travis, S.; Filice, M.; Massimino, L.; et al. (Journal of Crohn's & Colitis, 2026)